← Back to Search

Vitamin Supplement

Open label for Vitamin D Deficiency (VitD/RNA-seq Trial)

Phase 2
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up scheduled prostate biopsy at baseline and repeat biopsy after 1 year
Awards & highlights

VitD/RNA-seq Trial Summary

This trial is testing whether giving veterans vitamin D3 supplements will help lower stress levels and improve prostate health.

Eligible Conditions
  • Stress Reaction
  • Vitamin D Deficiency
  • Prostate Cancer

VitD/RNA-seq Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~scheduled prostate biopsy at baseline and repeat biopsy after 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and scheduled prostate biopsy at baseline and repeat biopsy after 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in transcriptional profiles after vitamin D supplementation.
Secondary outcome measures
Histopathology changes in the Gleason Score on repeat biopsy findings after vitamin D supplementation
Histopathology changes in the highest percentage of core involvement on repeat biopsy findings after vitamin D supplementation.
Histopathology changes in the number of positive cores on repeat biopsy findings after vitamin D supplementation.
+1 more

VitD/RNA-seq Trial Design

1Treatment groups
Experimental Treatment
Group I: Open labelExperimental Treatment4 Interventions
All enrolled subjects will receive vitamin D3 at 4,000 IU daily for approximately one year.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard of Care Prostate Biopsies at baseline and after one year vitamin D3 supplementation
2019
Completed Phase 2
~40
Allostatic Load Measurements at baseline and after one year vitamin D3 supplementation
2019
Completed Phase 2
~40
Standard of Care Prostate Biopsy - collection of 13th core for RNA-seq
2019
Completed Phase 2
~40
cholecalciferol
2011
Completed Phase 4
~3570

Find a Location

Who is running the clinical trial?

Ralph H. Johnson VA Medical CenterFED
18 Previous Clinical Trials
5,558 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,323 Total Patients Enrolled
1 Trials studying Vitamin D Deficiency
330 Patients Enrolled for Vitamin D Deficiency
MUSC Psychiatry and Behavioral SciencesUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans
Stephen Savage 2019. "Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04621500.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top